Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Research Coverage on Small and Micro-Cap Companies

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Equity Bottom-Up

<ul>
<li>Medicus Pharma Ltd. (TSXV:MDCX) is focused on acquiring or partnering with life-science companies that are developing novel therapeutics for unmet healthcare needs that are already in the clinical trial stage.</li>
<li>Management plans fast-track these specific therapies through FDA clinical trials toward commercialization.</li>
<li>The company's first acquisition was SkinJect, which has a novel, patented transdermal patch for the treatment of BCC.</li>
</ul>


Medicus Pharma Ltd. (TSXV:MDCX) is focused on acquiring or partnering with life-science companies that are developing novel therapeutics for unmet healthcare needs that are already in the clinical trial stage.
Management plans fast-track these specific therapies through FDA clinical trials toward commercialization.
The company's first acquisition was SkinJect, which has a novel, patented transdermal patch for the treatment of BCC.


Medicus Pharma Ltd. - Medicus Submits Updated Phase 2 Clinical Protocol

Canada

Theratechnologies, Inc. is a specialty pharmaceutical company that discovers and develops therapeutic peptide products, with an emphasis on growth-hormone releasing factor peptides. The Company's main product is being marketed in the United States for the reduction of excess abdominal fat n HIV-infected patients with lipodystrophy.

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company acquires and licenses pharmaceutical products. Knight offers its products to the healthcare industry around the world.

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of immunosuppressive therapeutics.

InMed Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops cannabis-based botanical and non-botanical therapies through research and development into the extensive pharmacology of cannabinoids. InMed Pharmaceuticals focuses on its proprietary platform technology, drug discovery, and commercialization development.

Cronos Group Inc. operates as a diversified and vertically integrated cannabis company. The Company offers production and distribution platforms of medical marijuana, as well as cultivates cannabis oil. Cronos Group serves customers in Canada.

Medical Facilities Corp owns controlling interests in specialty surgical hospitals, located in South Dakota and Oklahoma, as well as ambulatory surgery centers in California.

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.

Bausch Health Companies Inc. discovers and distributes pharmaceutical. The Company develops drugs for unmet medical needs in central nervous system disorders, eye health, and gastrointestinal diseases, as well as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetic devices. Bausch Health Companies serves customers worldwide.

Extendicare Inc. provides post-acute and long-term senior care services. The Company has a network of owned and operated health care centers that provide skilled nursing care, rehabilitative therapies, and home health care services.

Sienna Senior Living Inc. provides long-term care services. The Company offers nursing homes, retirement homes, and independent living facilities. Sienna Senior Living serves senior citizens in the State of Ontario.

Cynata Therapeutics Ltd is involved in regenerative medicine.  The Company is focused on the commercialization of a stem cell platform.

Genematrix Inc. provides diagnostics & therapeutic solution.  The Company's services are based on Restriction Fragment Mass Polymorphism (RFMP) technology and applied to theranostics, prognosis, and molecular diagnosis.

China Regenerative Medicine International Limited is engaged in research and development of bio-medical and healthcare products, and medical techniques, the provision of the production and sales of tissue engineering products and its related by-products, as well as sales and distribution of medical products and equipment.

Gene Techno Science Co., Ltd. is a biomedicine company that researches and developes drugs. In addition to drug development, the company also supply the pharmaceutical ingredients.

Daesung Microbiological Labs Co., Ltd. develops and manufactures canine, poultry, swine, and bovine drugs and vaccines.  The Company's products have applications for increasing immunity and preventing epidemic for livestock. Daesung Microbiological Labs also researches microorganism for ocean and soil improvement purposes.

TRANS GENIC INC. develops, produces, and sells specific idiotype bearing antibody (bio reagent).  The Company also develops mutant mice and sells mice' genetic function analysis data.

Ribomic, Inc. develops ribonucleic acids (RNA) called aptamers. The company conduct research and develops new medication based on Ribomic Aptamer Refined Th erapeutics System. The company also conduct advisory to pharmaceutical companies and product licensing.

Aspira Women's Health Inc. operates as a biotech company. The Company develops and discovers testing and treatments for gynecologic issues. Aspira Women's Health serves customers in the State of Texas.

Prescient Therapeutics Limited is an oncology company. The Company researches, develop, and commercializes novel cancer treatments treatments. Prescient Therapeutics treats myeloma, breast, and pancreatic cancer.

vTv Therapeutics Inc. operates as a clinical-stage pharmaceutical company. The Company focuses on the discovery and development of human therapeutics to fill unmet medical needs. vTv Therapeutics serves customers in the United States.

Medicus Pharma Ltd. is a clinical stage, multi-strategy holding company. The Company focuses on investing in and accelerating novel disruptive life sciences and bio-technology companies through FDA approved clinical trials. Medicus Pharma serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Medicus Pharma Ltd. - Medicus Submits Updated Phase 2 Clinical Protocol

Management plans fast-track these specific therapies through FDA clinical trials toward commercialization. The company's first acquisition was SkinJec

Zacks Small Cap Research